Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Biocelect Pty Ltd
Administration route
Subcutaneous injection
Vaccine group
Japanese encephalitis vaccines
Description:
Registered for use in people aged ≥9 months.
Live attenuated Japanese encephalitis vaccine
Lyophilised powder in a monodose vial with separate diluent.
Each 0.5 mL reconstituted dose contains:
- 4.0–5.8 log plaque-forming units of live attenuated recombinant Japanese encephalitis virus
- mannitol
- lactose
- glutamic acid
- potassium hydroxide
- histidine
- human serum albumin
No adjuvants or antibiotics are added.
For Product Information and Consumer Medicine Information about Imojev visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Page history
Last updated
Last reviewed
Related diseases